Sentence examples for changed mdt from inspiring English sources

The PET-CT confirmed CTS findings for 147 (61.8%) and changed MDT recommendations in 91 patients (38.2%) by (i) identifying M1 disease (n=43), (ii) refuting CTS suspicions of M1 disease (n=25), and (iii) identifying new lesions required for investigations (n=23).

2 This was an indicator to modify or change WHO MDT, aiming at a more effective, safe, compliant, and shorter-duration regimen that is free from the fear of the emergence of resistant lepra bacilli.

Interestingly, the MDT changed their decision in only half of these cases (n=14).

The noncompliance rates towards the MP were modelled for the discordant cases: adjuvant treatment decision according to MDT-assessment low risk/MP high risk (4 out of 8 were discordant, 4 adjuvant decisions were changed; 50% noncompliance) and MDT-assessment high risk/MP low risk (11 out of 21, 10 adjuvant decisions were changed; 52% noncompliance).

The addition of PET-CT to standard staging for oesophageal cancer led to changes in MDT recommendations in 93 (38.2%) patients, improving patient selection for radical treatment.

It is assumed, therefore, rather than certain, that the PET-CT findings were accurate and resulted in a correct change in MDT recommendation.

If, therefore, the reference point is changed to the week of the first reported cases, then MDT of the WCR method will not be more than 2 weeks.

The conversion operation of samples had been changed from scanning to curving by the conductive diamond tips of AFM (DCP11, NT-MDT, CO).

Analyzing the metabolic response of MDT-10 to LNA, signals in the 1 to 3 ppm region were greatly changed and some of the compounds were successfully identified.

During hypnosis significantly changed somatosensory thresholds (reduced function) were observed for the following sensory detection thresholds: Cold Detection Threshold (CDT), Warm Detection Threshold (WDT), Thermal Sensory Limen (TSL) and Mechanical Detection Threshold (MDT).

The influence of PET-CT on MDT decision making was examined by establishing whether the PET-CT confirmed CTS findings of M0 disease (and did not change the patient staging pathway) or whether the PET-CT changed the pathway by showing unsuspected M1 disease, refuting CTS suspicious metastases, or identifying another lesion (needing further investigation).